Oak Ridge Investments’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-35,023
Closed -$330K 180
2018
Q4
$330K Sell
35,023
-134,062
-79% -$2.02M 0.02% 166
2018
Q3
$3.4M Sell
169,085
-25,155
-13% -$657K 0.19% 112
2018
Q2
$5.67M Sell
194,240
-20,677
-10% -$638K 0.32% 101
2018
Q1
$6.4M Sell
214,917
-58,783
-21% -$1.9M 0.36% 99
2017
Q4
$8.81M Sell
273,700
-147,284
-35% -$4.81M 0.42% 87
2017
Q3
$14.6M Buy
+420,984
New +$13.5M 0.59% 68

Other funds holding LJPC

Oak Ridge Investments's LJPC Position: Q1 2019 in Review

Oak Ridge Investments sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2019, closing a stake of 35,023 shares — an estimated $330K sold.

Oak Ridge Investments first reported a position in LJPC in Q3 2017 and held it in 6 quarters. The position peaked at $14.6M in Q3 2017. 80 funds tracked by Wall St. Rank hold LJPC as of Q1 2019.

  • Oak Ridge Investments reported no remaining La Jolla Pharmaceutical Company position as of Q1 2019 after selling out during the quarter.
  • Oak Ridge Investments sold 35,023 La Jolla Pharmaceutical Company shares in Q1 2019, an estimated $330K.
  • Oak Ridge Investments first reported a position in La Jolla Pharmaceutical Company in Q3 2017 and held it in 6 quarters.
  • Oak Ridge Investments's La Jolla Pharmaceutical Company position peaked at $14.6M in Q3 2017.
  • 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2019.

Based on Oak Ridge Investments's 13F filing for Q1 2019, filed 9 May 2019.